Who
Cambrian BioPharma Inc
10% owner
Company insider
Files Form 4 as: 10% owner and Other, Sensei Biotherapeutics.
In numbers
- Trades disclosed
- 91
- Buys
- 62
- Sells
- 4
- Bought
- $4.2M
- Sold
- $1.3M
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 3 Feb 2021
- Last trade
- 1 Jun 2026
- Last filed
- 1 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 1 Jun 2026filed 1 Jun 2026 | Sensei BiotherapeuticsBiotechnology | SEC FORM 4 Sold | $490K24,524 at $20.00 | filing |
| 1 Jun 2026filed 1 Jun 2026 | Sensei BiotherapeuticsBiotechnology | SEC FORM 4 Sold | $10K476 at $21.14 | filing |
| 1 Jun 2026filed 1 Jun 2026 | FTH Faeth TherapeuticsBiotechnology | SEC FORM 4 Sold | $490K24,524 at $20.00 | filing |
| 1 Jun 2026filed 1 Jun 2026 | FTH Faeth TherapeuticsBiotechnology | SEC FORM 4 Sold | $10K476 at $21.14 | filing |
| 9 Dec 2025filed 10 Dec 2025 | FTH Faeth Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —395 at $0.00 | filing |
| 9 Dec 2025filed 10 Dec 2025 | FTH Faeth TherapeuticsBiotechnology | SEC FORM 4 Sold | $27K3,105 at $8.59 | filing |
| 9 Dec 2025filed 10 Dec 2025 | FTH Faeth TherapeuticsBiotechnology | SEC FORM 4 Sold | $21K2,666 at $7.95 | filing |
| 9 Dec 2025filed 10 Dec 2025 | FTH Faeth TherapeuticsBiotechnology | SEC FORM 4 Code M | $2,528395 at $6.40 | filing |
| 9 Dec 2025filed 10 Dec 2025 | FTH Faeth TherapeuticsBiotechnology | SEC FORM 4 Sold | $3,176395 at $8.04 | filing |
| 9 Dec 2025filed 10 Dec 2025 | FTH Faeth TherapeuticsBiotechnology | SEC FORM 4 Sold | $3,532446 at $7.92 | filing |
| 5 Dec 2025filed 8 Dec 2025 | FTH Faeth TherapeuticsBiotechnology | SEC FORM 4 Sold | $165K14,508 at $11.40 | filing |
| 5 Dec 2025filed 8 Dec 2025 | FTH Faeth TherapeuticsBiotechnology | SEC FORM 4 Sold | $21K1,745 at $12.29 | filing |
| 5 Dec 2025filed 8 Dec 2025 | FTH Faeth TherapeuticsBiotechnology | SEC FORM 4 Sold | $55342 at $13.16 | filing |
| 4 Dec 2025filed 8 Dec 2025 | FTH Faeth TherapeuticsBiotechnology | SEC FORM 4 Sold | $45K5,000 at $9.06 | filing |
| 21 May 2025filed 23 May 2025 | FTH Faeth Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —19,000 at $0.00 | filing |
| 11 Jun 2024filed 13 Jun 2024 | FTH Faeth Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —19,000 at $0.00 | filing |
| 31 Jul 2023filed 2 Aug 2023 | FTH Faeth TherapeuticsBiotechnology | SEC FORM 4 Code D | $2.0M1,587,302 at $1.26 | filing |
| 10 Jul 2023filed 12 Jul 2023 | FTH Faeth Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —14,550 at $0.00 | filing |
| 10 Jul 2023filed 12 Jul 2023 | FTH Faeth TherapeuticsBiotechnology | SEC FORM 4 Code A | —4,466 at $0.00 | filing |
| 10 Jun 2022filed 7 Mar 2023 | FTH Faeth Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —14,550 at $0.00 | filing |
News
Sensei Biotherapeutics (NASDAQ:FTH) Shares Down 7% – Should You Sell?FTH · dailypolitical.com · 13 Oct 2026
0 headlines in the last 90 days name Cambrian BioPharma Inc; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.